Pages that link to "Item:Q2861938"

The following pages link to Surrogate Measures and Consistent Surrogates (Q2861938):

Displaying 21 items.

• Assessing the value of a censored surrogate outcome (Q118842) (← links)
• Causal measures of the treatment effect captured by candidate surrogate endpoints (Q887978) (← links)
• An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference (Q2827172) (← links)
• On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
• Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
• Robust methods to correct for measurement error when evaluating a surrogate marker (Q6055522) (← links)
• Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
• Proportion of treatment effect mediated by surrogate endpoints (Q6067311) (← links)
• Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
• Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design (Q6104106) (← links)
• Power of testing for exposure effects under incomplete mediation (Q6590286) (← links)
• Assessing heterogeneity in surrogacy using censored data (Q6618309) (← links)
• Data fusion for predicting long-term program impacts (Q6618383) (← links)
• Surrogacy validation for time-to-event outcomes with illness-death frailty models (Q6625395) (← links)
• Semiparametric pseudo-score and pseudo-likelihood for evaluating correlate of protection in vaccine trials (Q6626858) (← links)
• Quantifying the feasibility of shortening clinical trial duration using surrogate markers (Q6628174) (← links)
• Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm (Q6628202) (← links)
• Estimation of the proportion of treatment effect explained by a high-dimensional surrogate (Q6628359) (← links)
• Identifying surrogate markers in real-world comparative effectiveness research (Q6629372) (← links)
• Using a surrogate with heterogeneous utility to test for a treatment effect (Q6629910) (← links)
• Flexible evaluation of surrogate markers with Bayesian model averaging (Q6630321) (← links)